Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
17
XXII Quote, Financials, Valuation and Earnings
Last price:
$1.78
Seasonality move
:
-3.49%
Day range:
$1.75 - $1.82
52-week range:
$1.68 - $581.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
0.27x
Volume:
119K
Avg. volume:
104.5K
1-year change:
-99.33%
Market cap:
$952K
Revenue:
$32.2M
EPS (TTM):
-$8,358.46
22nd Century Group Number of Institutional Trades
22nd Century Group Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$757.6M
(Last 6 Months)
Current Institutional Ownership Percentage
5.45%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$1.2B
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
22nd Century Group Institutional Ownership
-
What Percentage Of XXII Is Owned by Institutions?
5.45% of XXII is owned by institutions.
-
How Many Institutions Own XXII Shares?
22nd Century Group stock is owned by 63 institutional shareholders at this time.
-
Have Institutions Been Buying XXII Stock?
Yes, institutions have bought 16M shares of XXII in the last quarter.
-
Have Institutions Been Selling XXII Stock?
Yes, institutions have sold 665K shares of XXII over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
